HoldingsChannel.com
| Date | Insider | Price | Amount |
|---|---|---|---|
| 3-5-2024 Insider Buy |
Casdin Capital, LLC Director and >10% Owner |
$8.74 CAGR » |
$357,652.30 40,900 shares |
| 11-17-2023 Insider Buy |
Jason Ryan Executive Chairman |
$1.41 CAGR » |
$161,367.97 114,742 shares |
| 11-8-2023 Insider Buy |
Richard C. Pfenniger Jr. Director |
$1.49 CAGR » |
$14,889.00 10,000 shares |
| 8-17-2023 Insider Buy |
Richard C. Pfenniger Jr. Director |
$5.10 CAGR » |
$25,523.00 5,000 shares |
| 1-31-2023 Insider Buy |
School OF Medicine AT Mount Sinai Icahn >10% Owner |
$0.35 CAGR » |
$9,999,999.80 28,571,428 shares |
| 1-26-2023 Insider Buy |
OPKO HEALTH, INC. >10% Owner |
$0.35 CAGR » |
$4,999,999.90 14,285,714 shares |
Also See: Institutional Holders of WGS
Also See: SEC filings
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 03/06/2024 | |
| End date: | 05/02/2024 | |
| Start price/share: | $8.05 | |
| End price/share: | $19.50 | |
| Dividends collected/share: | $0.00 | |
| Total return: | 142.24% | |
| Annualized Gain: | 927.07% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $24,224.00 | |
| Years: | 0.15 | |
GeneDx Holdings Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent GeneDx Holdings insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding WGS
 Free WGS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
|
|
|
Other companies seeing insider buying close in time to when the GeneDx Holdings Insider Buying occurred are:
Electromed Insider Buying
|
